Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2019

01-06-2019 | Antibiotic | Editorial

Hot topics and cold lecture halls: the ECCMID 2019

Author: Johannes R. Bogner

Published in: Infection | Issue 3/2019

Login to get access

Excerpt

Again, the ECCMID was a big success for the organisers as well as for roughly 13,500 participants from 120 countries: infectious disease clinicians, microbiologists, researchers, and representants of diagnostic and therapeutic industrial manufacturers. The scientific programme according to the programme director Winfried V. Kern was composed from 5311 regular scientific abstract submissions and additional 142 late-breaker submissions originating from more than 100 countries. In addition to Paper-, Poster- and e-Poster Sessions, 132 Oral Talk sessions were presented, most of them simultaneously. …
Literature
1.
Pradier M, Robineau O, Boucher A, et al. Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients. Infection. 2018;46:39–47.CrossRefPubMed
2.
Staats K, Sevelda F, Kaider A, et al. The influence of antibiotic-loaded cement spacers on the risk of reinfection after septic two-stage hip revision surgery. Infection. 2017;45:885–91.CrossRefPubMedPubMedCentral
3.
4.
5.
6.
Weinberger DM, Pitzer VE, Regev-Yochay G, Givon-Lavi N, Dagan R. Association between the decline in pneumococcal disease in unimmunized adults and vaccine-derived protection against colonization in toddlers and preschool-aged children. Am J Epidemiol. 2019;188:160–8.CrossRefPubMed
7.
Forsblom E, Kakriainen A, Ruotsalainen E, Jarvinen A. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study. Infection. 2018;46:837–45.CrossRefPubMed
8.
Jung N, Rieg S. Essentials in the management of S. aureus bloodstream infection. Infection. 2018;46:441–2.CrossRefPubMed
9.
10.
Lubbert C, Baars C, Dayakar A, et al. Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens. Infection. 2017;45:479–91.CrossRefPubMed
Metadata
Title
Hot topics and cold lecture halls: the ECCMID 2019
Author
Johannes R. Bogner
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01310-9

Other articles of this Issue 3/2019

Infection 3/2019 Go to the issue

Images in Infection

18F-FDG PET/CT monitoring of non-tuberculous mycobacterial infection in a child with interleukin-12 receptor β-1 deficiency

Brief Report

Vertebral osteomyelitis due to Candida species

Case Report

Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization

Case Report

Actinomyces spp. bloodstream and deep vein thrombus infections in people who inject drugs

Original Paper

Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage

Original Paper

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits